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LETTER 
“He uttered a cry and was seen to be rubbing his hands together. His pulse was 
immediately examined for but was not palpable” [1].  
Hypoxia is a biological stimulus capable of promoting both rescue and survival 
mechanisms, as well as triggering a sequence of irreversible events that lead to death 
of cell, tissue and even individual. Brain and heart functions depend critically on 
adequate energy supply and they are highly susceptible to hypoxic conditions. 
Adequate oxygen supply is needed for the brain and heart to metabolize glucose as 
its major energy source. But how many type of hypoxia we know, and how much 
severe is the hypoxic condition, when more than one type of hypoxia are 
simultaneously acting?  Four types of hypoxia are distinguished in medicine: α- the 
hypoxemic hypoxia, due to a decrease in the amount of breathable oxygen or 
cardiopulmonary failure, b- the anemic hypoxia related with decreased amount of 
functional hemoglobin, c- the stagnant hypoxia, secondary to reduced or unevenly 
distributed flow of blood distribution to the tissues, and mainly result from heart 
disease that impairs the circulation; and d- the histotoxic hypoxia, in which the tissue 
cells are poisoned and are therefore unable to make proper use of oxygen [2].  
A highly sensitive and complex mechanism capable of identifying the hypoxic 
condition was developed by eukaryotic cells, which give rapid responses to rescue or 
to cell death induction. These ambivalent responses to hypoxia (acute or chronic) is 
mediated by the transcription factor "Hypoxia Inducible Factor 1-α" (HIF‐1α), 
described originally by Greg L. Semenza, who won the Nobel Prize 2019 for this 
discovery. HIF-1α plays a master role in the stimulation and/or repression of a large 
list of genes, which will modify the functionality of the cells that undergo said 
modifications induced by HIF-1α under hypoxic conditions. Thus, after any hypoxic 
event, the nuclear translocation of HIF-1α is an unequivocal marker off hypoxic 
suffering by the affected cell, and it should be related to the increase and loss of 
expression of the genes up-regulated and down-regulated by HIF-1α respectively 
[3]. Between these large gene list, erythropoietin and erythropoietin receptor genes, 
are also up-regulated by HIF-1α [4]. The P-glycoprotein (P-gp) encoded by MDR-
1/ABCB-1 gene, is responsible for the multidrug-resistant phenotype and it is also 
induced by HIF-1α [5].  
Normal cerebral oxygenation may be modified during or immediately after a 
seizure, and inversely brain hypoxia can further increase seizure 
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susceptibility. Because O2 acts as the final electron acceptor in 
the mitochondrial electron transport chain to generate ATP in 
eukaryotic cells, during O2 deprivation (hypoxia), a closely 
relationship with tissue inflammation will be developed. In this 
context, it is important to highlight that cerebral hypoxia, either 
global hypoxia, as well as focal hypoxia due to 
cerebrovascular accident or stroke may to have heterogeneous 
characteristics with multiple etiologies, and taken together, 
brain hypoxia represents the second disease with the greatest 
cause of sequelae of disability or death in the world [6].  
Brain hypoxia triggers molecular processes leading to neuronal 
damage, where ATP production can falls more than 50%, and 
neurons lose the ability to maintain the membrane potential 
and suffering progressive depolarization [7]. This complex 
mechanism that is involved in the onset of seizures was also 
observed in experimental apneas [8]. Stroke (ischemic or 
hemorrhagic) as well as cardiac arrest related brain injury, are 
two major causative factors for seizure development, however, 
the underlying pathophysiology of seizure development is not 
well understood [9]. 
One important alert is that seizures arising within two weeks of 
the initial stroke or cardiac event are generally categorized as 
“early-onset”. Early-onset seizures are primarily observed 
within 24 hours of the initial insult and are considered a 
medical emergency as life-threatening status epilepticus may 
development. Similar observations have been reported cases 
with seizures arising after stroke events. In spite two different 
types of hypoxia are involved by heart arrest (stagnant 
hypoxia) and stroke (histotoxic hypoxia) respectively, both 
conditions can lead to the same consequence: “seizures or status 
epilepticus” development. Interestingly, the fine mechanisms 
underlying leading to convulsive episodes are not clearly 
understood. 
Experimentally in aging mice, it was also demonstrated that 
brain Hypoxia-Ischemia (HI) can induce early-onset seizures, 
closely associated with severe brain injury and acute mortality; 
however prophylactic anticonvulsive treatment can inhibit 
seizures development and improve survival in post-HI aging 
mice [10].  
After cardiopulmonary arrest, seizures are a common problem 
in the intensive care unit, occurring in as many as one-third of 
these patients during their hospitalization. Furthermore, whether 
seizures exacerbate global hypoxic-ischemic brain injury in 
human’s remains unclear, which raises uncertainty about how 
aggressively they should be treated. Some pathological data 
suggest that anoxic brain injury is worsened by Generalized 
Tonic-Clonic (GTC) Status Epilepticus (SE). On very important 
features of these particular situations (hypoxia plus seizures, or 
seizures during hypoxia), is that Status Myoclonus (SM) in 
hypoxic-ischemic coma is particularly troublesome, because it 
can be highly refractory to conventional anticonvulsants and 
appears to portend an extremely poor prognosis, regardless 
of its management [11]. 
Patients with epilepsy often experience acute repetitive 
seizures or seizure clusters, with negative impact on quality of 
life, emotional wellbeing, daily function, and productivity of the 
patients and their caregivers. These seizure cluster, are 
characterized by more than 2 seizures occurring in periods 
between 6 to 24 hours [12]. After the pioneer and potential 
first description sudden death during epileptic crisis by Russell 
above mentioned, Sudden Unexpected Death in Epilepsy 
(SUDEP) should be assumed as a very likely “final chapter of a 
convulsive-life” for a group of patients with RE, whom haven not 
control of seizures under therapy with several recommended 
Antiepileptic Drugs (AEDs). Some risk factors for SUDEP have 
been identified, such as repetitive Generalized Tonic–Clonic 
Seizures (GTCS), male sex, poor compliance with AEDs 
prescription, youth, early age at seizure onset, or being in bed 
at the time of death [13]. In these patients, a multidrug-
resistant phenotype is usually developed, and brain P-gp over 
expression is one of more common finding [14].  
SUDEP determination excludes sudden cardiac death, as by 
definition, it does not include known causes of mortality as 
cardiac co-morbidities [15]. Additionally to the SUDEP 
definition, the concept of “Epileptic Heart” has been recently 
reported as “a heart and coronary vasculature damaged by 
chronic epilepsy as a result of repeated hypoxemia with 
increased catecholamines leading to electrical and mechanical 
heart dysfunction” [16]. This concept was supported by clinical 
evidences showing a higher percentage of heart disease in 
patients with chronic epilepsies, as compared with patients 
without epilepsy story [17]. Interestingly, in these patients with 
chronic epilepsies, the also chronic therapy with several AEDs 
should be assumed as not-successful treatment. In this regards, 
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perhaps the most severe stress related with epilepsy could lead 
to Takotsubo Syndrome (TKS) development, and its potential 
relationship with SUDEP was suggested [18]. In two 
experimental studies of chronic and acute heart hypoxia-
ischemia, a significant loss of 99mTc-2-Methoxyisobutylisonitrile 
(99mTc-SESTAMIBI) heart retention in the affected ischemic heart 
regions with a concomitant high expression of P-gp have been 
demonstrated to be associated heart stunning [19,20]. 
In this regards, TKS was included into this spectrum of stress-
related cardiomyopathies, where heart stunning was 
documented [21], and heart hypoxic-ischemia was postulated 
[22]. Both acute as chronic epileptic seizures can to provoke 
cardiac ischemia and develop several effects on the heart as 
impaired heart rate variability, ST-segment depression, 
cardiac fibrosis, increased heart rate, or severe bradycardia. 
Transient ischemia in heart can be observed after each seizure 
but if seizures are frequents, this transient condition could turn 
to a condition of chronic heart ischemia [23,24]. 
The intermittent hypoxia is broadly defined as repeated 
episodes of hypoxia interspersed with episodes of normoxia. 
The actual protocols used experimentally vary greatly in cycle 
length, the number of hypoxic episodes per day, and the 
number of exposure days [25]. Chronic Intermittent Hypoxia 
(CIH) is the most distinct feature of Obstructive Sleep Apnea 
(OSA), a common breathing and sleep disorder that leads to 
several neuropathological consequences, including alterations in 
the hippocampal network and high seizure susceptibility. In this 
regards, 21 days of CIH increases gamma-band hippocampal 
network activity and aggravates 4-aminopyridine-induced 
epileptiform activity adult rats, and these CIH-induced 
alterations remit after 30 days of normal oxygenation [26]. In 
an experimental model of Intermittent Hypoxia (IH) during 
sleep, it was demonstrated the brain up-regulation of both 
Hypoxia Inducible Factor 1 Alpha (HIF-1α) and the P-
glycoprotein (P-gp) [27], which was also detected in the heart 
of these rats (data not shown). 
After injection in brain rats of the chemical a hypoxiating 
compound as CoCl2, nuclear translocation of HIF-1α was 
detected concomitantly with P-gp expression in neurons and 
vascular endothelial cells, and also co-expressed with 
erytrhopoietin receptor, a classic HIF-1α responsive gene [28-
30]. Similar results were also observed after repetitive PTZ-
induced seizures, and a relationship with SUDEP was suggested 
[31]. In this regards, experimental repeated pilocarpine-
induced Status Epilepticus (SE), resulted in the HIF-1α nuclear 
translocation and high P-gp expression in cardiomyocytes, 
associated to Electrocardiographic (ECG) changes such as QT 
interval prolongation, bradycardia and a high rate of 
spontaneous death [32]. Furthermore, in a preliminary 
experimental study developed under these same above 
mentioned conditions in rats, an important reduction of 99mTc-
SESTAMIBI heart retention 72 h after pilocarpine-induced SE 
with a high P-gp expression in cardiomyocytes and associated 
with high sudden death ratio were observed [33].  
Although the mechanism that triggers sudden death is unknown, 
evidences suggest that SUDEP could be due to heart failure as 
consequence of a high hypoxic-stress with excessive 
sympathetic overstimulation triggering a neuro-cardiogenic 
injury, and affecting the electrical properties of myocardium 
that lead to heart failure with fatal arrhythmia (bradycardia). 
All these evidences suggest that the highly accumulated burden 
of convulsive stress results in a hypoxic heart insult, where P-gp 
expression play a depolarizing role in cardiomyocytes 
membranes.  
In addition, other molecular regulators of membrane potential 
in both neurons and cardiomyocytes are the inwardly rectifying 
potassium channels (Kir), whose genetic variants have been 
related to both epilepsy and heart dysfunctions. In heart, they 
control cell excitability by acting towards the repolarization 
phase of cardiac action potential [34]. Based on this property, 
it would be logical to assume that dysfunction or absence of Kir 
channel as a deleterious mechanism which gives more durability 
to the cardiomyocytes membranes depolarization, induced by 
hypoxia and favored by the over-expression of P-gp as 
mentioned above. Effectively, after PTZ-induced repetitive 
seizures in rats, molecular analyses showed a significant 
decrease in mRNA and protein expression of cardiac Kir 
channel [35], associated with a over-expression of HIF-1a in 
these cardiomyocytes (data not show). 
Since erythropoietin receptor (EPO-R) gene is also a hypoxia-
inducible gene, it has been suggested that exogenous 
administration of erythropoietin could have an antiapoptotic 
and rescue effect not only at the brain level but also at the 
cardiac level [36,37]. It is important to highlight that P-gp is 
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normally absent in neurons and cardiomyocytes, and the 
hypoxic-induced P-gp expressions in these cells, are not only 
related to its pharmacoresistant property. Pioneer studies have 
demonstrated that P-gp can modify the resting membrane 
potential, producing depolarization with values from -70 to -
10mV in the expressing cells [37,38]. These specific 
observations are in total concordance with the mechanistic 
property of 99mTc-SESTAMIBI, that bind to mitochondrial 
membrane but it is released out off the cell by P-gp under 
membrane depolarization as above mentioned [39]. This 
depolarization has been also observed yippocampus and 
neocortex after repetitive seizures induced by PTZ in rats 
where P-gp was highly expressed [40].  
All these data suggest that seizures, induces a hypoxic 
condition not only at brain, but also in heart, with an increased 
expression of P-gp and the simultaneously loss of Kir 
expression in cardiomyocytes. These up and down regulations, 
play a central combined role to develop a sustained 
depolarization of cardiomyocytes, leading to a potential fatal 
heart failure, after a new seizure. This situation can be clearly 
detected by Single-Photon Emission Computed Tomography 
(SPECT) images of myocardial perfusion, using 99mTc-
SESTAMIBI, a tracer of P-gp functional expression in 
cardiomyocytes [41]. Reduced 99mTc-SESTAMIBI heart retention, 
is a hallmark of heart depolarization and ischemia, and it can 
be a noninvasive high risk predictor of SUDEP in patients with 
RE. 
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